Showing 7771-7780 of 9978 results for "".
- World Congress for Hair Research Convenes in Texashttps://practicaldermatology.com/news/world-congress-hair-research-convenes-texas/2463139/Hundreds of internationally renowned scientists and clinicians interested in hair research gathered in Dallas, Texas, from April 6-9, for the 13th World Congress for Hair Research. Hosted by the American Hair Research Society (AHRS), a member of the International Federation of Hair Res
- Reflections on the “Clearly Me” Psoriasis Exhibithttps://practicaldermatology.com/news/reflecting-on-clearly-me-psoriasis-exhibit-a-qa-with-lindsay-adler/2463137/The “Clearly Me” exhibit in New York, New York, held from May 16-18, showcased real psoriatic patients through dynamic photographic portraits, captured by photographer L
- Research IDs New Psoriasis Inflammation Pathwayhttps://practicaldermatology.com/news/research-ids-new-psoriasis-inflammation-pathway/2463125/Researchers from a recent study have identified a key biological pathway responsible for the inflammation seen in psoriasis, with potential implications for other inflammatory diseases like atopic dermatitis, allergic dermatitis, and hidradenitis suppurativa. The study, published in the j
- InnoCare Completes Patient Enrollment in Phase 2 Trial of ICP-488 for the Treatment of Psoriasishttps://practicaldermatology.com/news/innocare-completes-patient-enrollment-phase-2-trial-icp-488-treatment-psoriasis/2463108/InnoCare Pharma announced the completion of patient enrollment for the phase 2 clinical trial of ICP-488, a tyrosine kinase 2 (TYK2) JH2 allosteric inhibitor, for the treatment of psoriasis. The multicenter, randomized, double-blind, placebo-controlled phase 2 study aims to evaluate the e
- PHOTOS: "Clearly Me" NYC Event Highlights Psoriasis Journeys of Patientshttps://practicaldermatology.com/news/photos-clearly-me-nyc-event-highlights-psoriasis-journeys-patients/2463107/AbbVie recently held a dynamic, photo-centric event at High Line Nine Galleries in New York City highlighting the psoriasis journeys of several patients through photographs. The exhibit, called Clearly Me, aimed to raise awareness about psoriatic disease by telling the stories of these p
- Oral HSP90 Inhibitor Gets Positive Feedback From FDAhttps://practicaldermatology.com/news/oral-hsp90-inhibitor-gets-positive-feedback-fda/2463023/A first-in-class oral drug candidate for the treatment of hidradenitis suppurativa (HS) received positive feedback from a pre-Investigational New Drug meeting with the US Food and Drug Administration (FDA), according to a press release. MC2 Therapeutics, a commercial stage biotech company
- LEO Pharma Announces Topline Results of Phase 3 Trial in China for Plaque Psoriasis Treatment Enstilarhttps://practicaldermatology.com/news/leo-pharma-announces-topline-results-phase-3-trial-china-plaque-psoriasis-treatment-enstilar/2463007/LEO Pharma announced results from the Enstilar phase 3 trial in China in adult patients living with stable plaque psoriasis. The trial is a phase 3, randomised, investigator-blind, active controlled, parallel group, multicenter trial comparing the efficacy and safety of once daily Enstila
- Meta-Analysis: Avelumab Offers Hope for Advanced MCC Patientshttps://practicaldermatology.com/news/meta-analysis-avelumab-offers-hope-for-advanced-mcc-patients/2463006/A recent meta-analysis indicated that avelumab monotherapy and combination therapy shown improvement in overall response and survival rates in patients with advanced Merkel cell carcinomas (MCC). The study, published in Dermatologic Surgery, surveyed results from 48 studies invol
- Dermal Fillers Connected to Body Dysmorphia Disorder?https://practicaldermatology.com/news/dermal-fillers-connected-body-dysmorphia-disorder/2462981/A recent Forbes article suggests a potential connection between dermal fillers and body dysmorphic disorder (BDD), a condit
- GLODERM Announces CeraVe Access Grant Recipientshttps://practicaldermatology.com/news/gloderm-announces-access-grant-recipients/2462970/Five dermatologists working in low-resource settings around the world have been awarded $20,000 each as part of the International Alliance for Global Health Dermatology (GLODERM) Mentorship Programme, which aims to increase access to dermatological care in under-served communities. The new GLODER